It’s part of a congressional probe lawmakers believe may show links to President Donald Trump and other former top officials.

Developed by Autolus Therapeutics, AUCATZYL is approved to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). This follows prior authorizations from ...